La Jolla, CA · Founded 2021 · Privately Held (backing)
Operator of a clinical-stage biotechnology company intended to pioneer new precision medicines for autoimmune neuropsychiatric diseases. Arialys Therapeutics is based in La Jolla, CA and was founded in 2021. It was valued at $112 million at its seed round in Jun 2025, the last priced event on record. It has raised $72 million across 2 recorded rounds; the latest was a $14.8 million early-stage round in Jun 2025.
PMV mark · valuation
$112.0M
Oct 2026
Priced at
its seed round
Jun 2025
Total raised
$72.0M
Last round
Early Stage VC
Jun 2025
Cap table — not yet on record
Arialys Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Arialys Therapeutics with a free account
·Watch Arialys Therapeutics: the Monday email on marks, rounds and moves
Where does Arialys Therapeutics's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Arialys Therapeutics's 2 recorded funding rounds.
